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Abstract. 
 
Proteins with expanded polyglutamine
(polyQ) tracts have been linked to neurodegenerative
diseases. One common characteristic of expanded-polyQ
expression is the formation of intracellular aggregates
 
(IAs). IAs puriﬁed from polyQ-expressing cells were
 
dissociated and studied by protein blot assay and mass
spectrometry to determine the identity, condition, and
relative level of several proteins sequestered within
aggregates. Most of the sequestered proteins comigrated
with bands from control extracts, indicating that the se-
questered proteins were intact and not irreversibly
bound to the polyQ polymer. Among the proteins found
sequestered at relatively high levels in puriﬁed IAs
were ubiquitin, the cell cycle–regulating proteins p53
and mdm-2, HSP70, the global transcriptional regulator
Tata-binding protein/TFIID, cytoskeleton proteins actin
 
and 68-kD neuroﬁlament, and proteins of the nuclear
pore complex. These data reveal that IAs are highly com-
plex structures with a multiplicity of contributing proteins.
Key words: polyglutamine • Huntington’s disease •
aggregates • inducible expression • ecdysone receptor
 
Introduction
 
CAG repeat expansion and concomitant polyglutamine
 
(polyQ)
 
1
 
 expression have been linked to a variety of neuro-
 
degenerative conditions including Huntington’s disease
(HD), dentatorubro-pallidoluysian atrophy, spinocerebellar
ataxia (including types 1, 2, 3, 6, 7, and 12), and spinobulbar
muscular atrophy (Holmes et al., 1999; Zoghbi and Orr,
2000). The relationship between the expression, distribu-
tion, and aggregation of proteins with expanded polyQ
 
tracts and cell death remains to be understood. To date,
most of the progress in determining the molecular events
surrounding polyQ toxicity has concentrated on mammalian
and invertebrate transgenic models (Reddy et al., 1999;
Zoghbi and Orr, 2000), viral gene transfer models (Senut et
al., 2000), and transfection studies with a variety of polyQ-
 
containing gene products (Reddy et al., 1999; Zoghbi and
Orr, 2000).
One common hallmark of these diseases and other neuro-
degenerative conditions, including Alzheimer’s disease and
Parkinson’s disease, is the formation of insoluble protein
aggregates and inclusion bodies in disease-specific regions
of the human brain (for reviews see Perutz, 1999; Wanker,
2000). What is not clear in polyQ-mediated pathologies,
however, is that, although intracellular aggregates (IAs)
may correlate to a greater or lesser extent with disease pro-
gression, they have not been causally linked to the death of
affected cells (Sisodia, 1998). Furthermore, aside from the
polyQ-bearing protein, the composition of IAs remains
largely unknown.
 
Some proteins known to be colocalized to polyQ IAs are
components of protein-folding and proteolytic pathways.
These proteins include ubiquitin, molecular chaperones,
and components of the 20S proteasome. Recent studies in
 
transgenic mouse and 
 
Drosophila melanogaster
 
 models of
polyQ-mediated toxicity reveal that inhibition or pertur-
bation of these cellular pathways can significantly suppress
cytotoxicity of expressed polyQ proteins in vivo
 
 
 
(Sherman
and Goldberg, 2001).
Other proposed components of IAs are proteins with
nonpathogenic length polyQ tracts and caspases. IA re-
cruitment of synthetic reporter proteins with short polyQ
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tracts, and sequestration of intracellular factors with tracts
as short as 19 glutamines, such as CREB-binding protein,
have been demonstrated (Kazantzev et al., 1999). A second
endogenous protein with a nonpathogenic but longer poly-
glutamine tract (38 glutamines), TATA-binding protein
(TBP) (Kao et al., 1990), has also been colocalized to IAs in
tissue samples from HD patients (Huang et al., 1998). The
protease caspase-8 has been described as a component of
IAs in Hela cells transiently transfected with a 79Q con-
struct (Sanchez et al., 1999).
To date, the majority of studies have assayed recruit-
ment or sequestration of proteins to IAs by immunohis-
tochemical colocalization of antibodies to IAs stained with
established IA markers, generally antiubiquitin or an anti-
body against the polyQ protein itself. The benefit of this
type of analysis is that differences in the staining pattern
or intensity of staining from one IA to another may pro-
vide information on heterogeneity within the IA popula-
tion, which in turn may yield valuable clues as to the
pathogenesis of polyQ-mediated cell death. One drawback
of this type of analysis is that many antigens may be
masked or conformationally altered by association with
the IA and could lead to false negative conclusions or mis-
leading staining patterns. Furthermore, it is difficult to as-
sign a quantitative value to positive structures in immuno-
cytochemical studies.
In this report, we describe the isolation, characteriza-
tion, and composition of IAs from an inducible in vitro
model of polyQ-mediated disease using a human cell line
that standardizes several parameters of polyQ-mediated
cell death. Through a combination of protein blot analysis,
immunohistochemical studies, and proteomics using ma-
trix-assisted laser desorption ionization time of flight mass
spectrometry (MALDI) analysis (Yates, 2000), the identi-
ties and relative levels of aggregate-associated proteins
were examined. These studies reveal that IAs are complex
structures with a multiplicity of sequestered protein com-
ponents.
 
Materials and Methods
 
Construction of polyQ Reporter Fusion Proteins
and Vectors
 
PolyQ reporter constructs were made by PCR amplification of human
Huntingtin (Htt) exon I variants with 13- and 96-CAG tracts, preserving
polyproline (polyP) sequences immediately downstream of the polyQ
tract (see Fig. 1) and fusing these fragments in frame to the NH
 
2
 
 terminus
of EGFP (CLONTECH Laboratories, Inc.) in the cloning vector SKSP.
Unique AscI and MluI restriction sites were inserted into the 5
 
9
 
 and 3
 
9
 
coding regions for insertion of oligonucleotides encoding the SV 40 nu-
clear localization signal (NLS). For the experiments in this report, only
the 3
 
9
 
-localized SV 40 NLS was used. The 96Q tract contains a character-
ized arginine residue at position 42 of the 96Q tract
 
 
 
(Senut et al., 2000).
The polyQ–eGFP coding region was excised from SKSP using unique SfiI
and PmeI cloning sites for insertion into retroviral vector NIT (sequence
data available from GenBank/EMBL/DDBJ under accession number
AF311318) for expression in transient transfection studies, or into retrovi-
ral vector LPR for use with vector CVBE for ecdysteroid-induced cells.
LPR is a Moloney murine leukemia virus–based vector with puromycin
resistance and six-tandem ecdysone response elements fused to a minimal
cytomegalovirus (CMV) promoter directing transgene expression when
combined with CVBE (Suhr et al., 1998). Transient transfection analysis
was performed by calcium phosphate precipitation by standard methods.
For nuclear visualization, cells were stained with either 100 ng/ml propid-
ium iodide or DAPI.
 
Cell Transfection, Retroviral Infection, and
Cell Culture
 
Transient transfection by calcium phosphate precipitation and transfec-
tion to produce replication-defective retrovirus was as previously de-
scribed (Pear et al., 1993; Suhr et al., 1998). All cell cultures were done in
DME with 10% FBS in a 10% CO
 
2
 
 environment. For retroviral infection,
low titer (multiplicity of infection 
 
,
 
0.1) polyQ–green fluorescent protein
(GFP) virus variants were used. Infection, selection, and passage of cells
were performed as described for other G418-resistant cell types (Suhr et
al. 1998). Production of CVBE–LPR coinfected cells was as described for
CVBE with MS (Suhr et al. 1998), except that 2 
 
m
 
g/ml puromycin was
used for selection of LPR-infected cells. For studies of ligand responsive-
ness, individual cell populations were passaged to either 24- or 6-well Cos-
tar plates. For stimulation of infected cells, 1 
 
m
 
M tebufenozide or vehicle
(90% ethanol) was added and replaced only when cells were passaged or
the media was changed. For the Western blot time course of induction, 10-
cm plates were seeded with 2.5 
 
3
 
 10
 
5
 
 13QN or 96QN cells. One set of
plates was immediately treated with 1 
 
m
 
M tebufenozide for the 6-d time
point, 48 h later for the 4-d time point, and so on. Cells were fed on day 3,
and ligand was replaced if necessary. All cells were simultaneously har-
vested at the end of the experiment, collected by scraping in PBS, pelleted
by low-speed centrifugation, and resuspended in 250 
 
m
 
l cold 10 mM Tris-
Cl, pH 7.5. The resuspended pellet was then sonicated on ice with 30 1-s
bursts at 30% power, the protein concentration was quantified, and ali-
quots of the preparations were frozen at 
 
2
 
70
 
8
 
C until use in protein blot
analysis as outlined below.
 
TUNEL Staining
 
DNA fragmentation was detected in situ on cultured cells using the immu-
nocytochemical terminal deoxynucleotidyl transferase–mediated dUTP–
biotin end labeling (TUNEL) technique (Roche) according to the manu-
facturer’s protocol. Using sheep antifluorescein antibody (Roche), the
fluorescein signal was converted into a peroxidase signal for visualization
using 0.025% DAB, 0.5% nickel chloride, and 0.018% H
 
2
 
O
 
2
 
 in TBS. Posi-
tive and negative controls were included in each experiment.
 
IA Purification
 
IAs were purified using a modification of the CsCl gradient procedures
described by Scherzinger et al. (1999). PolyQ cells were grown on 10- or
15-cm plates with 1 
 
m
 
M tebufenozide treatment for 5 d, feeding and pas-
saging as necessary, but maintained at 
 
.
 
50% confluency. The plates of in-
duced cells were then washed two times with PBS, the cells were collected
by scraping in a small volume of PBS, centrifuged to pellet cells, and the
pellet was resuspended in 3 ml of cold lysis buffer (50 mM Hepes-KOH,
pH 7.4, 150 mM NaCl, 1.5 mM MgCl, 1 mM EGTA, 0.02% sodium azide,
1% NP-40, 10% glycerol, 0.1 mg/ml PMSF). Lysis proceeded on ice for 30
min. The lysate was vortexed vigorously and centrifuged in a microfuge at
1.6 
 
3
 
 10
 
4
 
 
 
g
 
 for 5 min at 4
 
8
 
C. The insoluble pellet(s) were collectively resus-
pended in 1 ml of 20 mM Tris, pH 8.0, 15 mM MgCl, and sonicated with 30
1-s bursts at 30% power. 100 
 
m
 
g of DNase was then added, and the mix-
ture was incubated at 37
 
8
 
C for 1 h. After incubation, the lysate was
brought up to a final volume of 4 ml with 10 mM Tris HCl, pH 7.5, and dry
CsCl was added to a final concentration of 0.16 g/ml. 4 ml of a 0.52 g/ml
CsCl Tris solution was placed in an ultracentrifuge tube, overlaid with an
equal volume of 0.25 g/ml CsCl solution, and then topped off with the 4 ml
of lysate CsCl. This step gradient was centrifuged at 1.1 
 
3 
 
10
 
5
 
 
 
g
 
 for 24 h in
a ultracentrifuge (Beckman Coulter). After centrifugation, thin bands of a
greenish hue (that were brightly fluorescent under 495-nm excitation
wavelength illumination) were observed 
 
z
 
1/2–2/3 from the top of the
tube. These bands were collected in a volume of 200–300 
 
m
 
l and diluted 50
times (to 
 
z
 
15 ml) with 10 mM Tris-Cl, pH 7.5. The diluted IAs were cen-
trifuged at 5
 
 3 
 
10
 
3
 
 
 
g
 
 three times with repeated dilution (sonicating as
needed to break up IA clumps). The final pellet was resuspended in 100–
300 
 
m
 
l of 10 mM Tris, aliquoted, and frozen at 
 
2
 
70
 
8
 
C until use.
 
Protein Blot Analysis and Quantification
 
For Western blot analysis, cell lysates and preparations of purified aggre-
gates were heated in loading buffer (50 mM Tris-HCl, pH 6.8, 10% SDS,
0.1% bromophenol blue, 10% glycerol). Equal amounts of protein (
 
z
 
7.5
 
m
 
g) were loaded in each lane of a 10% SDS-PAGE gel and electropho-
resed. Gels were subsequently transblotted to nitrocellulose membranes
using a liquid transfer apparatus (Bio-Rad Laboratories). Membranes 
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were blocked for 1 h in blocking solution (5% nonfat milk in TBS-Tween)
and incubated overnight at 4
 
8
 
C with primary antibodies (Table I) diluted
in blocking solution. After extensive washes, membranes were incubated
for 1 h with peroxidase-conjugated secondary antibodies (1:1,000–1:5,000),
and immunoreactive signals were visualized using a chemiluminescence
detection kit (Amersham Pharmacia Biotech). Control experiments were
carried out by replacing the primary antibody with normal serum or pread-
sorbing the primary antibody with the corresponding peptide antigen.
For quantification of sequestered proteins, each antibody used to de-
tect a sequestered protein species in the Western blot analyses (see Fig. 3)
was titrated against increasing concentrations of induced 96QN cell whole
cell extracts or purified IA samples to determine the linear range of detec-
tion (data not shown). Each antibody was reassessed against the same
samples as those described in the legend to Fig. 3 using an amount of pro-
tein and dilution of antibody determined to be within the linear range of
detection. From these protein blots, the integrated densities of bands
within purified IA lanes and control lanes were determined and used to
calculate the percentage of protein for an individual protein species se-
questered into IAs relative to the amount of the same protein in whole
cell extracts. Since no recruited protein species displayed different band
intensities in the 5-d induced 13QN and 96QN uninduced lanes, these two
values were averaged to provide the basal protein expression level.
To calculate degree of sequestration, two parameters were established.
The first parameter established the number of whole cell extract equiva-
lents of IAs per unit volume of purified IAs relative to a unit weight of
96QN–GFP whole cell extracts. By quantifying the intensity of the poly-
merized 96QN–GFP band for 5 
 
m
 
l of purified IAs sample relative to the
polymerized 96QN–GFP band for 7.5 
 
m
 
g 96QN–GFP whole cell extracts,
it was determined that this value averaged 16.3, indicating that the amount
of IA protein in 5 
 
m
 
l of purified IAs represents the amount of IA protein
in 7.5 
 
m
 
g 
 
3
 
 16.3, or 
 
z
 
122 
 
m
 
g of 5-d 96QN–GFP whole cell extract. For
blots in which the amount of purified IAs or whole cell extract was re-
duced or increased to bring detection within the linear range, the correc-
tion factor was proportionally adjusted.
Since only a subpopulation of cells at the time of harvest contained
large IAs likely to equilibrate within the CsCl gradient band taken during
purification, a second parameter was determined that corrected for IA
heterogeneity within the 96QN–GFP cell population. 18% of cells dis-
played large IAs at the 5-d time point, so, to normalize to whole cell ex-
tracts, the protein adjusted value was divided by 0.18 to produce the final
value reported.
 
Protein Isolation and MALDI Analysis
 
For isolation of individual protein bands from IA preparations, 40 IA
equivalents (relative to the amount used in protein blot analyses above) in
a volume of 80 
 
m
 
l (a 2.5
 
3
 
 relative concentration) prepared for gel loading
as above, were subjected to 10% SDS-PAGE on a 1-mm slab gel and run
at low constant voltage (90 V) for 8 h. The gel was then stained overnight
with 40% methanol, 10% acetic acid, 0.25% Coomassie brilliant blue and
destained for 8 h the next day in 40% methanol, 10% acetic acid solution.
Four prominent stained bands that ranged in size from 
 
z
 
70 to 30 kD were
excised from the gel with a scalpel, transferred to a microfuge tube,
treated with TFA–acetonitrile for 1 h at 37
 
8
 
C, and vacuum lyophilized.
The lyophilized samples were treated with trypsin for 16 h at 37
 
8
 
C, and
peptides were extracted according to Bienvenut et al. (1999). Extracted
peptides were dried by vacuum centrifugation and applied to the MALDI
sample plate via use of C18 Ziptips (Millipore). The sample was dissolved
in 10 
 
m
 
l 0.1% TFA and 5% acetonitrile, applied to a Ziptip, and equili-
brated in the same buffer (see manufacturer’s instructions). The bound
peptides were washed with the same buffer (4 
 
3
 
 10 
 
m
 
l) and then eluted
with 0.1% TFA, 80% acetonitrile, 10 mg/ml 
 
a
 
-cyano-4-hydroxy-trans-cin-
namic acid (
 
z
 
1 
 
m
 
l) directly onto the MALDI plate. MALDI analysis was
accomplished using a Voyager RP (PerSeptive Biosystems) with internal
calibration using insulin (5,734 Da) and a synthetic peptide LAP 821
(1,740 Da). Between 10 and 23 peaks with closely matching peaks on sam-
ples run without internal calibration were used to challenge public protein
databases using Protein Prospector (http://prospector.ucsf.edu) and Pro-
Found (http://prowl.rockefeller.edu) (Zhang and Chait, 2000). Values
were compared with both mammalian and human protein databases at
lower (
 
6
 
200–500 ppm) and higher (
 
6
 
1,000 ppm) mass tolerances.
 
Immunohistochemistry
 
Antisera used in these studies are listed in Table I.
 
Cell Culture. 
 
Cells were fixed for 20 min in phosphate-buffered 4%
paraformaldehyde and rinsed twice in 0.1 M TBS. Primary antibodies
were diluted in 0.1 M TBS containing 5% normal donkey serum and 0.3%
Triton X-100 (NDST). Cells were preincubated in 5% NDST for 1 h at
room temperature and then incubated in the primary antibodies overnight
at 4
 
8
 
C. Cells were rinsed three times in 5% NDST and incubated for 2 h at
room temperature with donkey secondary antibodies (Jackson Immu-
noResearch Laboratories) conjugated to FITC, cyanin-3, or cyanin-5, and
diluted 1:250 in 5% NDST. Cells were then washed five times in 0.1 M
TBS, with the third wash containing 10 ng/ml 4, 6-diamidino-2-phenylin-
dole (Sigma-Aldrich) for nuclear staining. TRITC–phalloidin staining was
performed by incubating fixed cultured cells in 30 nM TRITC–phalloidin
for 30 min followed by extensive rinsing with PBS.
 
Human Tissue. 
 
Postmortem caudate–putamen tissues from control
(
 
n
 
 5 
 
3) and age matched HD grade 3 (
 
n
 
 5 
 
3) patients (mean age: 70.8 yr;
range: 60–78 yr) were obtained from the Harvard Brain Tissue Resource
Center, Cambridge, MA. Tissue blocks were cryoprotected at 4
 
8
 
C in in-
creasing concentrations of phosphate-buffered sucrose (10, 20, and 30%).
Coronal serial 40-
 
m
 
m-thick sections were cut on a freezing microtome,
collected either in 0.1 M TBS for immediate immunostaining, or in cryo-
protectant for further storage at 
 
2
 
20
 
8
 
C. Free-floating sections were
placed in 0.3% hydrogen peroxide for 20 min and then preincubated in
0.1 M TBS containing 5% normal donkey serum, 5% normal AB human
serum, and 0.3% Triton X-100 (5% NHDST) for 2–4 h at room tempera-
ture. Sections were then incubated in the primary antibodies (Table I) di-
luted in 5% NDHST for 72 h at 4
 
8
 
C. Sections were rinsed three times in
5% NDHST, incubated for 1 h at room temperature with the adequate
biotinylated donkey secondary antibodies (Jackson ImmunoResearch
Laboratories) diluted 1:200 in 5% NDHST, rinsed twice in 0.1 M TBS,
and incubated with an avidin–biotin peroxidase complex (1:120) for 1 h at
room temperature. After intense rinses in 0.1 M TBS, tissue-bound perox-
idase was visualized using 0.025% DAB, 0.5% nickel chloride, and
0.018% H
 
2
 
O
 
2
 
 in TBS. Sections were rinsed, mounted on gelatin-coated
slides, dried, and coverslipped.
 
Results
 
Expression and Aggregation of polyQ–GFP
Fusion Proteins
 
Long (96Q) and short (13Q) polyQ tracts derived from
human Htt exon I (Huntington’s Disease Collaborative
Research Group, 1993) were fused to a GFP reporter pro-
tein to produce 96Q–GFP and 13Q–GFP constructs (Se-
nut et al., 2000), as shown in Fig. 1 a. Unique sequences
were designed into the regions flanking the polyQ tracts to
allow insertion of SV 40 NLS and other sequences either
COOH- or NH
 
2
 
-terminal to the polyQ tract. A long
 
Table I. Characteristics of the Antisera
 
Antigen Origin Host Dilution/Western IFL
Actin
 
James Lessard
 
Mouse 1:1,000/1:3,000
Caspase-3 Santa Cruz Biotechnology, Inc. Rabbit 1:250–500/1:50
Caspase-8 Santa Cruz Biotechnology, Inc. Rabbit 1:250–500/1:50
Caspase-9 Santa Cruz Biotechnology, Inc. Rabbit 1:250–500/1:50
GFP Santa Cruz Biotechnology, Inc. Rabbit 1:3,000/NA
GRB-2 Santa Cruz Biotechnology, Inc. Rabbit 1:1,000/1:100–250
HSP70 Transduction Laboratories Mouse  NA/1:100
HSP70 Santa Cruz Biotechnology, Inc. Goat 1:500/1:100
Huntingtin Chemicon Rat 1:500/1:50
Lamin B Santa Cruz Biotechnology, Inc. Goat 1:500/1:500
mdm-2 Ab-1 (N) Santa Cruz Biotechnology, Inc. Rabbit 1:100/1:50
mdm-2 Ab-2 (C) Santa Cruz Biotechnology, Inc. Rabbit 1:100/1:50
MEF-2a Santa Cruz Biotechnology, Inc. Rabbit 1:500/1:100
Nck Santa Cruz Biotechnology, Inc. Rabbit 1:500/1:250 
Neurofilament 68 kD Chemicon Rabbit 1:1,000/1:500
NPCP/mAb414 Babco Mouse 1:1,000/1:3,000
p53 Santa Cruz Biotechnology, Inc. Rabbit 1:500/1:100
TBP Santa Cruz Biotechnology, Inc. Rabbit 1:1,000/1:100–200
Ubiquitin Dako Rabbit 1:1,000/1:100 
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polyproline tract was located immediately COOH-termi-
nal to the polyQ tract as in native Htt (Fig. 1 a). PolyQ–
GFP constructs were inserted either into a constitutive ex-
pression vector for pilot studies and testing by transient
transfection or into the regulated reporter retroviral vec-
tor system CVBE–LPR shown in Fig. 1 a. Fluorescent mi-
croscopy of cells transiently transduced with 13Q–GFP ex-
pression plasmids revealed that transfected cells expressed
GFP at high levels throughout the cytoplasm and nucleus
(Fig. 1 b). Addition of an SV 40 NLS resulted in efficient
localization of the 13QN–GFP reporter protein to the nu-
cleus, as shown in Fig. 1 c. Transfected 96Q–GFP and
96QN–GFP expression constructs, on the other hand,
initially displayed uniform GFP-positive fluorescence
throughout the cytoplasm or nucleus but, within 24–72 h of
transfection, condensed into the bright granules indicative
of IAs (Fig. 1, d and e). Most cells displayed one or two
IAs, and IAs were found within the cytoplasm, surround-
ing the nuclear envelope, and within the nucleus itself. At
higher magnification, IAs were observed to have a stellate
appearance with fibrous projections emanating from a
central core (Fig. 1 f). In the absence of the NLS, IAs were
approximately evenly divided between the cytoplasm and
nucleus. The addition of the NLS resulted in 
 
.
 
90% peri-
nuclear/nuclear localization of IAs (data not shown).
To circumvent the toxic consequences of chronic consti-
tutive polyQ expression, the polyQ–GFP fusion constructs
were used in a positively regulated retroviral vector sys-
tem (Suhr et al., 1998). Transactivator and reporter ret-
roviruses bearing the polyQ–GFP constructs were in-
troduced into HEK293 cells as described in Materials
and Methods.
 
 
 
Three inducible lines were produced:
CVBE–LPR–96Q–GFPQ–GFP (96Q), CVBE–96QN–
GFP (96QN), and CVBE–LPR13QN–GFP (13QN).
CVBE–LPR13Q–GFP cells were not included in the study
since preliminary experiments revealed that they were in-
distinguishable in all respects from the 13QN cell popula-
tion, except for localization of the polyQ–GFP protein. In
Fig. 1, g–l, inducible 13QN, 96Q, and 96QN cell lines were
stimulated with 1 
 
m
 
M tebufenozide and allowed to grow
for 
 
#
 
1 wk. In the absence of ligand, only widely scattered
cells (
 
,
 
0.1%) displayed even low green fluorescence (Fig.
1, g, i, and k). After ligand stimulation, green fluorescence
was rapidly observed and, as predicted from transient
transfection studies, displayed diffuse nuclear fluorescence
in 13Q/N–GFP cells (Fig. 1 h) and punctate intense posi-
tivity indicative of IAs by 72 h in 96Q- and 96QN-induced
cells (Fig. 1, j and l).
Western blot analysis of the time course of polyQ induc-
tion revealed a low level of 13QN expression in the ab-
sence of ligand that is increased 
 
z
 
50-fold to a steady state
 
IAs at high magnification. 72-h vehicle- (g) or ligand-treated (h)
13QN cells stained with the nuclear stain DAPI (red), vehicle- (i)
or ligand-treated (j) 96Q cells, and vehicle- (k) or ligand-treated
(l) 96QN cells. Bright GFP-positive profiles indicate IA formation.
(m) Western blot analysis of induced 13QN (left) or 96QN (right)
cells. Numbers at the top of each blot indicate the number of days
of induction. WELL, bottom of the well; RES, bottom of the
stacking gel and the beginning of the resolving gel. Bar: (b–e) 125
 
m
 
m; (f) 20 
 
m
 
m; (g–l) 250 
 
m
 
m.
 
Figure 1
 
. PolyQ–GFP reporter constructs transiently and regu-
latably expressed in HEK293 cells. (a, left) Schematic of polyQ–
GFP fusion proteins indicating Htt exon I–derived sequences
(white), SV 40 NLS (gray), and eGFP sequences (black). (a,
right) Schematic of CVBE and LPR Moloney murine leukemia
virus–based retroviral vectors used in production of inducible
polyQ cell lines. CVBE encodes flanking long terminal repeats
(LTRs), a G418-resistance gene (G418), the immediate–early
CMV promoter (CMV), and the VBE transactivator protein
(VBE). LPR encodes long term repeats, a puromycin-resistance
gene (Puro), a minimal CMV promoter with six tandem ecdysone
response elements (RE), and a SfiI–PmeI polylinker for insertion
of the polyQ transgenes. (b–f) Propidium iodide nuclear-stained
(red) HEK293 cells transiently transfected with the expression
construct 13Q–GFP (b), 13QN–GFP (c), 96Q–GFP (d), and
96QN–GFP (e). GFP produces the bright green fluorescence. (f)
IAs in transfected cells revealing stellate fibrous appearance of 
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level of expression within 48 h of ligand addition (Fig. 1 m,
left). A similar pattern is observed in 96QN-induced cells
(Fig. 1 m
 
,
 
 right); however, at times 
 
.
 
24 h after induction,
IA formation was observed with increasing frequency, as
evidenced by the increasing accumulation of insoluble ma-
terial within the stacking gel at the top of the blot. By day
6, there is an apparent loss of monomeric 96QN protein as
increasing free protein is trapped within the growing ag-
gregates.
 
Morphologic Changes and Increased Toxicity Induced 
by 96QN Expression
 
Study of induced cells revealed no obvious time-depen-
dent morphological changes in any of the induced lines
with the exception of 96QN, which at time points 
 
.
 
4 d ex-
hibited irregularities in nuclear morphology, including nu-
clear hypertrophy, the formation of small satellite struc-
tures of nuclear material, and an increase in the formation
of multinucleated syncitia. Fig. 2, a–d, shows examples of
the occasional multinucleated syncytia that form at 5 d af-
ter induction. One hallmark of these syncytia is the fre-
quent presence of large cytoplasmic IAs at the center of a
ring of nuclei (Fig. 2, a and c). The number of syncytia
within representative cell populations at different times af-
ter induction is shown in Fig. 2 e. At the 5-d time point,
96QN cells develop over fivefold more multinucleated
syncytia than 5-d 13QN cells, 96Q cells, or 96QN cells at
the earlier time points.
Changes in cellular/nuclear morphology paralleled a low
but detectable increase in cell death within the stimulated
polyQ–GFP populations. Fig. 2, f–i, shows TUNEL stain-
ing of a representative 96QN population stimulated for 5 d
with tebufenozide. A comparison of 13QN-, 96Q-, and
96QN-stimulated cells reveals that only nuclear-localized
long polyQ tract-producing cells displayed increased
TUNEL positivity during the 5-d time course of the exper-
iment (Fig. 2 j). At 3 d after induction, 97QN cells dis-
played over twofold more TUNEL-positive profiles than
other cell types and over
 
 
 
fivefold more TUNEL-positive
bodies by day 5, representing 
 
z
 
2% of the total cell popu-
lation.
 
Purification of IAs from Day 5 Induced 96QN Cells
 
IAs were purified from induced polyQ cells at the 5-d time
point (corresponding to the maximum change in cellular
morphology and cytotoxicity) using a variation of IA isola-
tion procedures described by Scherzinger et al. (1999).
Western blot analyses comparing either whole cell ex-
tracts or purified aggregates of different cell populations
are shown in Fig. 3, a–n. Fig. 3 a shows a blot of 5-d in-
duced whole cell extract from 13QN cells (lane 1), unin-
duced 96QN cells (lane 2), 5-d induced 96QN cells (lane
3), and purified IAs (lane 4) processed for detection of
GFP. In Fig. 3 a, monomeric 13QN is observed migrating
near an apparent molecular mass of 35 kD and monomeric
96QN near 52–53 kD as in Fig. 1 m. IAs are observed
throughout the stacking gel and accumulate at the extreme
top of the resolving gel. Anti-GFP staining localizes the
purified IAs (lane 4) almost exclusively at the top of the
resolving gel with only a weak band corresponding to mo-
nomeric 96QN. The low level of monomeric 96QN protein
indicates that, although the purified IAs are denatured,
they are not resolubilized into free monomers to a signifi-
cant degree. The possibility that 96QN polymers may be
covalently linked together by the action of transglutami-
nase is further discussed below.
To begin specific identification and characterization of
IA components, an identical blot to Fig. 3 a was probed
with antiubiquitin primary antibody to examine ubiquitin
sequestration within the purified IAs. Western blot for
ubiquitin (Fig. 3 b) revealed a positive signal in all four
lanes and substantially increased positivity in induced
96QN whole cell extracts, with most immunoreactive spe-
cies extending from 
 
z
 
50–60 kD up and into the stacking
gel (Fig. 3 b, lane 3). Ubiquitin staining in the purified IA
lane (Fig. 3 b, lane 4) reveals a significant intensification of
Figure 2. Morphological changes and cell death in induced
polyQ-expressing cells. (a–d) 5-d induced 96QN cells matched
fluorescence (a and c) and phase–contrast images (b and d), re-
vealing multinucleated syncitia-like cell structures. In a and c,
nuclei are red, and polyQ–GFP IAs are green. In b and d, red ar-
rowheads indicate the syncitia boundaries. (e) Quantification of
the number of syncitia-like structures/103 cells in a typical exper-
iment in each induced cell population at 0, 3, and 5 d. Numbers
indicate fold change relative to day 0. (f–i) TUNEL positivity in
induced 96QN cells. (f) Fluorescent view; (g) bright-field view
reveling DAB-stained TUNEL-positive profiles; (h) overlay of
both views; and (i) corresponding phase–contrast view. Arrows
in panel g indicate TUNEL profiles that were scored as positive
for quantification. Overlay and phase–contrast views reveal that
the TUNEL positive cells are often rounded up and resting just
above the monolayer of surviving cells below. (j) Quantification
of the number of TUNEL-positive profiles in a typical experiment
in each induced cell population at 0, 3, and 5 d. Numbers indicate
fold change relative to day 0. The slight increase in apoptotic cells
at 3 and 5 d for 13QN and 96Q cells is probably the consequence of
high cell density near the end of the culture period. Bar: (a–d) 50
mm; (f–i) 250 mm. 
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the pattern observed in lane 3, indicating a dramatic con-
centration of ubiquitin in the purified IA sample. The
smear of signal from 50 kD up likely represents ligated
ubiquitin polymers and other ubiquitinated species, in-
cluding 96QN polymers and other sequestered proteins.
After published reports of chaperone protein recruit-
ment described in the Introduction, we also examined se-
questration of the 70-kD heat shock protein HSP70 (Wu
 
et al., 1985). Western blot analysis of HSP70 also revealed
the presence of a significant amount of 70-kD HSP70 se-
questered within the purified IAs from the 5-d 96QN cells
(Fig. 3 c, lane 4). Unlike ubiquitin, which forms polymers
and covalent linkages to target proteins (Ciechanover,
1994), HSP70 is liberated from the IA in monomeric form
and displays an identical migration pattern to the three
control lanes. No HSP70 is detected at higher molecular
weights or within the stacking gel, suggesting that essen-
tially all of the sequestered HSP70 protein is released dur-
ing the boiling/SDS/
 
b
 
-mercaptoethanol treatment of the
IAs for loading.
Another class of protein either predicted or demon-
strated to be sequestered within IAs is proteins with non-
pathological length polyQ tracts, such as native Htt, TBP,
or myocyte-specific enhancer factor (MEF-2a) (Suzuki et
al., 1996). MEF-2a was detected at approximately equiva-
lent levels in each of the three control lanes, but could not
be detected in the purified IA lane even after prolonged
exposure (Fig. 3 d). Htt staining revealed a clear doublet
of high molecular weight bands of the correct size in the
control lanes but not in lane 4 (Fig. 3 e). Fig. 3 f reveals the
presence of significant sequestered TBP in the purified
IAs. No significant signal is detected at higher molecular
weights, and all signal is concentrated within the 
 
z
 
38-kD
band, suggesting that TBP is not cross-linked to the 96QN
polymer at the 5-d time of harvest.
A second class of protein potentially sequestered within
IAs are SH2/SH3 proteins capable of binding extended
polyP tracts (Sittler et al., 1998). We examined two polyP
binding proteins determined in pilot experiments to be de-
tected in HEK293 cells—Grb-2 (Lowenstein et al., 1992)
and a related protein, Nck (Lehmann et al., 1990). As
shown in Fig. 3, g and h, although both proteins were de-
tected at relatively high and equivalent levels in control
lanes, neither protein was detected in purified aggregates.
Members of the caspase family of cysteine proteases
were also examined because they are integral to the pro-
gression of apoptosis (Thornberry and Lazebnik, 1998)
and have been implicated in polyQ-mediated cell death
via possible recruitment to IAs (Sanchez et al., 1999). We
examined caspase-9 (Duan et al., 1996), caspase-8 (Muzio
et al., 1996), and caspase-3 (Fernandes-Alnemri et al.,
1994) (Fig. 3, i–k), which in pilot studies of HEK293 cells,
demonstrated detectable levels in whole cell extracts. Of
the three, only caspase-3 (Fig. 3 k) was clearly detected in
lane 4. There is also intensification of a high molecular
weight band up at the border of the resolving gel, which
may indicate that some level of caspase-3 is still trapped
within the 96QN polymer. Caspase-9 identification was
complicated by several nonspecific bands and an apparent
low level of expression and, though not observed to be se-
questered within IAs in these experiments, may be ob-
served in ongoing experiments in other cell types.
The final group of proteins examined for sequestration
were the tumor suppressor protein p53 (Lane and Craw-
ford, 1979) and the p53-regulating protein mdm-2 (Mo-
mand et al., 1992). Western blot analysis revealed that p53
was sequestered at high relative levels (Fig. 3 l). In addi-
tion, a tight triplet of additional p53-positive bands was ob-
served within the IAs at 
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48–50 kD that was not observed
in the control lanes. Mdm-2 was also observed in purified
Figure 3. Western blot analysis of protein sequestration in puri-
fied IAs and control whole cell extracts. For all protein blots:
lane 1, whole cell extracts from 5-d induced 13QN cells; lane 2,
uninduced 96QN cells; lane 3, 5-d induced 96QN cells; and lane 4,
isolated concentrated aggregates. Arrowheads at the right of
autoradiograms indicate predicted molecular weights of indi-
vidual protein species unless otherwise specified. (a) Processing
for polyQ–GFP immunoreactivity. 96-P indicates the position of
polyQN–GFP polymers within the stacking gel and near the top
of the resolving gel (lanes 3 and 4), 96-M indicates a low level of
96QN monomers (lanes 2–4), and 13-M indicates the 13QN
monomer band (lane 1). This autoradiogram was overexposed to
reveal the 96QN monomer bands in lanes 3 and 4. (b) Ubiquitin;
(c) HSP70; (d) MEF-2a; (e) Htt; (f) TBP; (g) Nck; (h) GRB-2; (i)
caspase-9; (j) caspase-8 (putative procaspase-8, upper arrowhead;
putative caspase-8 cleavage products, lower arrowheads); (k)
caspase-3; (l) p53 and p50 immunoreactive species (upper and
lower arrowheads, respectively); (m) mdm-2 antibody-1 (120-kD
variant, upper arrowhead; p60 variant, lower arrowhead); and (n)
mdm-2 antibody-2 immunoreactivity. 
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IAs at high levels (Fig. 3, m and n). Mdm-2 modulates p53
by binding and promoting the ubiquitination and subse-
quent proteolysis of p53 (Fuchs et al., 1998). An 
 
z58–60-
kD form of mdm-2 described in previous reports (Pocham-
pally et al., 1998) was the predominant mdm-2 species
observed, although a high molecular weight 120-kD band
was also detected within the control lanes (Fig. 3 m). Only
the 58–60-kD band was found to sequester within the IAs
and, like p53, displayed a second band of immunoreactivity
at a slightly lower molecular mass (56/57 kD), only within
the concentrated IAs in lane 4 (Fig. 3 m). Use of an mdm-2
antibody located further toward the COOH terminus in the
mdm-2 protein revealed only the 58–60-kD band and did
not detect the 56/57-kD band or the high molecular weight
band observed with the first antibody (Fig. 3 n). Immuno-
detection of the 56/57-, 58–60-, and 120-kD bands was
blocked by use of manufacturer-supplied blocking peptides
as described in Materials and Methods (data not shown).
MALDI Analysis of Predominant Protein Species
Fig. 4 a shows Coomassie-stained protein species in a con-
centrated IA sample on a 1-mm 10% SDS–polyacrylamide
gel. Four bands at z68, 54, 50, and 41 kD stood out as
much more prominent than the z30 other bands of lesser
intensity within the sharply resolved region of the gel from
100 kD to the dye front. These four bands were excised
from the gel and subjected to MALDI analysis to provide
tentative identification of each protein species.
12 peptide masses were used to query the peptide data-
base for the z68–70-kD protein band. 7 of the top 10
matches with 4/12 to 7/12 matched masses covering 10–19%
of the peptide were from the 68-kD light neurofilament pro-
tein (NFL) from a variety of species including human
(Julien et al., 1987). Subsequent protein blot analysis shown
in Fig. 4 b reveals not only that NFL is expressed at readily
detectable levels in the HEK293 cells but that it is also re-
cruited to IAs at high levels within the purified IA fraction.
Submission of 10 peptide masses for the 40–41-kD band
at lower mass tolerances returned no strong matches; how-
ever, resubmission of the same data set increasing the
mass tolerance returned all 10 top matches as various spe-
cies of the microfilament protein actin (Gunning et al.,
1983) with molecular mass ranges from 37.8 to 42.1 kD—
all in close agreement with the molecular weight of the ex-
cised band. Matched masses ranged from 6/10 to 8/10 and
covered 28–36% of the protein. Subsequent protein blot
analysis using an antiactin monoclonal antibody (Lessard,
1988), shown in Fig. 4 c, confirms detection in both control
lanes and high levels in purified IA preparations.
Identification of the 54-kD band with 10 submitted
weights returned no strong matches at low weight toler-
ance allowances; however, at higher error tolerance, two
proteins of the target molecular weight were returned with
four to five matches. The first was the DEAD box protein
Dbp-5 (5/10 matches) recently described by Schmitt et al.
(1999), with a predicted molecular mass of 53.9 kD, and
the second was RanBP3-a (4/10 matches), with a predicted
molecular mass of 53.2 kD (Mueller et al., 1998). RanBP3,
a splice variant of RanBP3-a, was also returned but has a
slightly higher molecular mass of 59.6 kD. Human Dbp-5
is an RNA-dependent ATPase and localizes within the cy-
toplasm and at the nuclear rim, interacting with the cyto-
plasmic fibrils of the nuclear pore complex (NPC) via the
NH2-terminal region of the nucleoporin CAN/Nup159p.
Dbp-5 is also a DEAD box protein, a family of RNA-
binding proteins involved in a variety of mRNA process-
ing and import/export functions (Schmitt et al., 1999).
RanBP3-a is one member of a family of Ran-GTPase
binding proteins (Dasso and Pu, 1998) involved in the reg-
ulation of nuclear transport that are also characteristically
associated with the cytoplasmic side of the NPC. Although
we could not directly examine Dbp-5 or RanBP3-a protein
expression by immunochemical methods, we could readily
examine recruitment of known associated NPC compo-
nents. Using mAb414 (Davis and Blobel, 1986), a well-
characterized monoclonal antibody against FXFG nu-
cleoporins collectively referred to in this report as NPC
proteins (NPCPs), we performed protein blot analysis on
the control extracts and concentrated IA preparations and
found a high level of association of NPCP components
with the purified IA fraction. The 62-kD size of the most
intense band (Fig. 4 d) suggests that this band represents
Nup62, a protein of the central gated channel of the nu-
clear pore involved in the trafficking of protein and
mRNA to and from the nucleus. At higher molecular
weights, three bands that correspond to the approximate
molecular weights of three other NPCPs known to cross-
react with mAb414—Nup153, Nup214/CAN, and Nup358/
RanBP2 (Ryan and Wente, 2000)—are also tentatively
identified. The recruitment of this multiplicity of NPC pro-
Figure 4. Protein and Western blot analyses of sequestered pro-
tein in concentrated IAs. (a) Coomassie-stained protein gel of
isolated IAs revealing multiple bands from z10 kD (dye) up to
the boundary of the stacking/resolving gel (stack). The four pre-
dominant bands used for MALDI analysis are labeled at the
right. Lane organization is as described in the legend to Fig. 3. (b)
Protein blot analysis of 68-kD neurofilament light polypeptide;
(c) protein blot analysis of actin; (d) protein blot analysis with
monoclonal antibody 414–detecting putative NPCP proteins Nup62,
Nup153, Nup214, and Nup358 as labeled; (e) protein blot analysis of
lamin revealing no detectable sequestration in purified IAs.The Journal of Cell Biology, Volume 153, 2001 290
teins suggests that the recruitment of both RanBP3-a and
Dbp-5 may likely stem from broad interaction with most,
if not all, of the NPC and associated components. To test
whether or not the identification of nucleoporins associ-
ated with the purified IAs represented IA association with
the nuclear envelope as a structure (i.e., via fortuitous
copurification of nuclear membranes), we probed an iden-
tical blot with the ubiquitous nuclear structural protein
lamin B. Fig. 4 e shows that, although lamins are readily
detected in the whole cell extracts in Fig. 4, lanes 1–3, no
lamin protein is detectable in the purified IA sample ei-
ther comigrating with native lamins or in the insoluble
polyQ protein higher on the gel.
The closest return for the remaining band at 50 kD ap-
proximating this molecular weight is Tat-binding protein-1
(TatBP-1; 49.1 kD) from human and mouse (8/23 matches,
21% of the peptide). TatBP-1 was characterized early on
for its interaction with the HIV Tat protein (Nelbock et
al., 1990) and has since been recognized as a component of
the 19S regulatory subunit of the 26S proteasome (Dubiel
et al., 1993). We were unable to confirm the identity of the
50-kD band as TatBP-1 by immunochemical methods us-
ing available antibodies, which may be due to technical
limitations or may indicate that the band is not TatBP-1.
Semiquantitative Analysis of Protein Sequestration 
into polyQ IAs
Our attempts to accurately quantify the purified IA sam-
ples by standard methods were unsuccessful due to the
lack of solubility of the sample. However, by titrating dif-
ferent sample volumes, taking multiple exposures of the
Western chemiluminescent assay, and performing scan-
ning densitometry on the resulting GFP positivity, we de-
termined that 5 ml of purified IAs contained 16.3-fold
more polymerized insoluble 96QN–GFP immunoreactiv-
ity than 7.5 mg of 5-d 96QN cell whole extract. Using this
value and semiquantitative protein blot analysis tech-
niques described in Materials and Methods, we deter-
mined the relative levels of individual protein species for
each cell type and treatment described in Figs. 3 and 4.
Comparison of individual protein species in the three
control lanes revealed that only ubiquitin displayed a dif-
ference greater than twofold between lanes. Ubiquitin was
increased z20-fold in 5-d 96QN whole cell extracts (Fig. 3
b, lane 3), compared with 13QN and uninduced 96QN
cells (Fig. 3 b, lanes 1 and 2). This increase likely repre-
sents an accumulation of ubiquitin protein on IAs as op-
posed to a dramatic increase in ubiquitin expression.
Relative sequestration of proteins to IAs is summarized
in Table II. Of the proteins tested (and excepting 96QN–
GFP itself and ubiquitin), p53 and Nup-p62 are the most
sequestered as a function of total cellular protein, with a
level equivalent to or exceeding the entire intracellular
pool sequestered in IAs. Other protein species are re-
cruited at levels of 13–58% of cellular stores with caspase-3
sequestered at the lowest level, ,1% of cellular stores.
For all of these proteins, but in particular for those that ap-
pear sequestered at lower levels, it must be kept in mind
that, if there is significant heterogeneity in IA sequestra-
tion, then the relative percentage of recruitment of an in-
dividual protein species may be dramatically increased in a
subpopulation of IA-containing cells.
Immunohistochemical Analysis of Sequestration into 
IAs In Vitro and In Vivo
Ubiquitin, HSP70, TBP, actin, and NPCPs could be local-
ized to IAs in 5-d 96QN cells or human postmortem tissue
from HD individuals. Ubiquitin (Fig. 5 a) and HSP70 (Fig.
5 b) were detected in vitro colocalizing with IAs of 96QN-
expressing cells, whereas HSP70 visualization required the
use of an alternate antibody from the antibody used for
protein blot analysis. Although not directly detected
within 96QN cell IAs in situ, an intensification of TBP pos-
itivity was observed in induced 96QN cells relative to un-
induced cells (Fig. 5, c and d). This intensification was de-
termined to localize with cells in later stages of apoptotic
cell death (Suhr, S., manuscript in preparation). Parallel
immunohistochemical localization experiments were per-
formed with postmortem striatal tissue samples from HD
individuals (n 5 3) and non-HD age-matched controls (n 5
3). Striatal tissue samples were examined for altered in-
tracellular distribution of each of the putative sequestered
proteins. Punctate ubiquitin-positive profiles were seldom
observed throughout the striatum of all three control cases
(Fig. 5 e) but were frequently observed in HD striatal sam-
ples (Fig. 5 f). Although HSP70 and caspase-3 displayed a
weak intensity of immunopositive staining in all tested tis-
sues, no obvious differences in the distribution pattern of
staining were observed between HD or control samples
(data not shown). Immunohistochemistry for TBP, on the
other hand, revealed the presence of scattered darkly posi-
tive profiles exclusively within the striatal samples of the
Table II. Protein Sequestration to IAs
Class Protein Seq to IA Polymer Relative seq
PolyQ 96QN-GFP 11 <2,000%*
PolyQ TBP 12 13.4%
PolyQ MEF-2a 2 NA NA
PolyQ Htt 2 NA NA
Proteolysis Ubiquitin 11 282.7%*
Proteolysis HSP70 12 14.9%
PolyP Grb-2 2 NA NA
PolyP Nck 2 NA NA
Protease Caspase-3 12 /1 0.4%
Protease Caspase-8 2 NA NA
Protease Caspase-9 2 NA NA
Cell cycle p53:53 kD 12  255.7%
Cell cycle p53:50 kD 12  191.4%‡
Cell cycle mdm-2 Ab 1:60 kD 12  32.2%
Cell cycle mdm-2 Ab 1:57 kD 12  24.5%‡
Cell cycle mdm-2 Ab 2:60 kD 12 31.9%
Structural NFL 12 57.7%
Structural Actin 12 26.6%
Structural nuclear Lamin B 2 NA NA
Structural nuclear NPCP-Nup62 12124%
Structural nuclear NPCP-NupHMW 12 NQ
Class, assigned group or class of protein. Protein, protein common name and molecular
mass of individual species (where applicable). Seq to IA, sequestration of protein to
IAs (1 indicates strong evidence of sequestration; 2 indicates no measurable
sequestration). Polymer, indicates whether protein blot analysis supports the presence
of higher molecular weight species consistent with isopeptide bond formation for
individual proteins (1 indicates strong evidence of polymerization; 2/1 indicates
potential polymerization; 2 indicates no evidence of polymerization; NA indicates
protein is not sequestered. Relative Seq, relative amount of sequestered protein to total
protein for each individual protein species. Where more than one protein band is
observed, the molecular weights indicate the band identity (NQ indicates that the value
was not quantified due to lack of corresponding signal detected in the control samples).
*Normalized to lane 3 given the increased signal intensity.
‡Normalized to 53-kD species for p53 or 60-kD species for mdm-2 since no band of
equivalent molecular mass was detected in control samples.Suhr et al. Proteins Sequestered in PolyQ Aggregates 291
three HD patients that were not observed in the age-
matched controls or after preabsorption with antigen (Fig.
5, g–i). Higher magnification of these inclusions revealed
two distinct types of structure: diffusely stained spheres of
various size and labeling intensity (Fig. 5, j and k) and in-
tensely stained inclusion-like objects with a halo of lighter
immunostaining (Fig. 5, l and m). These positive profiles
might correspond to a combination of the intensification
of antigen observed in the in vitro studies and localization
of TBP to polyQ IAs in a subset of these cells.
Although NFL colocalization to polyQ IAs has been de-
scribed in an earlier report (Nagai et al., 1999), we could
see no indication of IA colocalization or altered distribu-
tion of either NFL or actin in either HD tissues or induced
96QN cells by immunocytochemistry (Fig. 6, a and b). We
were, however, able to colocalize actin with IAs in induced
96QN cells using TRITC–phalloidin staining (Fig. 6, c–e).
This discrepancy supports the proposition that some IA-
sequestered proteins are not amenable to detection by im-
munological reagents.
NPCP immunohistochemistry revealed several distinc-
tive characteristics of IA colocalization not observed with
other antigens. First, it is apparent from the examples
shown in Fig. 6, f–h, that NPCP only colocalizes strongly
with a subset of IAs. Using a multiplicity of fluorescent la-
bels, two distinct populations of IAs are observed in Fig. 6
f: green fluorescent IAs, with little or no detectable contri-
bution of NPCP to the IA, and yellow IAs, indicating a
combination of the GFP fluorescence and CY3 red-
labeled NPCP. Secondly, in Fig. 6, g and h, a magnification
of this field indicates that some IAs are labeled around the
edges by NPCP antibody resulting in a halo pattern some-
times appearing associated with nuclei and, in other cases,
appearing separate from DAPI-stained nuclei. Third, in
addition to these halo structures, there are also examples
of smaller IAs in which NPCP positivity colocalizes with
the extent of the IA (Fig. 6, g and h, orange arrows). These
fainter IAs may not yet be true IAs but, instead, areas of
polyQ–GFP association with high density NPCP islands
on the nuclear lamina. These areas of NPCP density at the
nuclear periphery are not dependent on the presence of
polyQ–GFP accumulation, since numerous NPCP-dense
regions are observed with no apparent polyQ–GFP colo-
calization (Fig. 6 g, blue arrows).
Discussion
The observation that cell death increases shortly after the
widespread formation of IAs does not necessarily imply a
causal link between IAs and cell death; however, it also
does not rule out the possibility (discussed in Wanker,
2000). Many of the sequestered proteins are presumably
recruited through direct interaction with the polyQ-har-
boring protein, and this interaction may initiate with mo-
nomeric soluble polyQ proteins long before IA formation
itself takes place. The association of NPCP islands with
polyQ–GFP protein or weak IAs may represent this type
of early association. If IAs are, in fact, protective, a con-
cept that has been proposed in recent studies (i.e., Saudou
et al., 1998), knowledge of IA composition may lead to
strategies for accelerating specific sequestration of individ-
ual proteins through pharmacological or other means.
It is clear from these experiments that many different pro-
teins, in addition to the 96Q– and 96QN–GFP fusion peptide,
are sequestered within IAs. In addition, after denaturation of
IAs, and with the exception of ubiquitin and the 96Q pep-
tides themselves, the proteins that are sequestered present at
Figure 5. Immunohistochemical analyses of sequestered proteins
in 96QN cells and human HD striatum. (a) Colocalization of
ubiquitin (red) with IAs (green) resulting in uniform yellow color
of all IAs in transfected 96Q cells. Nuclei are in blue. Arrows in-
dicate colocalizing IAs. (b) Colocalization of HSP70 with IAs.
Arrows indicate some colocalizing IAs. (c) Uninduced 96QN
cells with infrequent intense TBP positivity (red) compared with
5-d induced 96QN cells (d) with frequent intensely TBP-positive
cells. 96QN–GFP IAs are green. (e) Ubiquitin-positive profiles in
the non-HD control striatum and in the HD striatum (f). Arrows
indicate punctate ubiquitin-positive profiles. (g–i) Localization of
TBP within punctate profiles in control striatum (g), HD striatum
(h), and HD striatum after preabsorbtion with peptide (i). Arrows
indicate TBP-positive profiles in HD tissue. (j–m) High magnifi-
cation of TBP-positive profiles in HD striatum revealing immunore-
activity in a diffuse sphere (j), a dark intense sphere (k), or punctate
profiles (l and m) with lighter surrounding immunopositivity.The Journal of Cell Biology, Volume 153, 2001 292
least one band comigrating with proteins from whole cell ex-
tracts, suggesting that at least some of the sequestered pro-
teins are likely to be full length and intact. It can be further
inferred that these proteins have not been targeted by ubiq-
uitin, have not been cross-linked to 96QN molecules (i.e., via
transglutaminase; Cooper et al., 1997; Kahlem et al., 1998), or
have not undergone irreversible polymerization, since higher
molecular weight immunoreactive species are not observed
at levels differing from control cell extracts.
MALDI Identification of NFL and Actin
Identification of NFL as a component of the IAs was un-
expected, given the nonneuronal nature of the HEK293
cell; however, it is tempting to speculate on the existence
of a pathological polyQ–NFL interaction that might ex-
plain limitation of polyQ-mediated disease manifestation
to neural tissues. The connection between polyQ, NFL,
and toxicity in HD remains to be established, but it is un-
likely that polyQ interaction with NFL is the sole mecha-
nism of cytotoxicity, since polyQ expression is toxic to es-
sentially every cultured cell type tested, and it is unlikely
that all cultured cells express NFL.
Actin, on the other hand is much more attractive as a
universal pathogenic component of polyQ-mediated toxic-
ity since it is expressed in every cell type and across phyla.
In addition, we have observed aberrant staining of 96QN–
GFP-expressing cells with an antimyosin monoclonal anti-
body, suggesting possible effects on the actin/myosin cy-
toskeleton (Suhr, S., manuscript in preparation). Actin
and myosin are also involved in mitosis and cytokinesis,
raising the possibility that the low-level syncitia formation
we observed arises from a cytokinesis defect due to
changes in actin dynamics. We have not observed a clear
difference in nonsequestered actin expression, distribution
between control and 96QN-expressing cells, or brain sec-
tions from human HD tissue, however, precluding us from
definitively identifying actin as an important component
of polyQ-mediated cytotoxicity.
Figure 6. Immunohistochemical fluorescent
confocal microscopy of protein species pre-
dicted by MALDI analysis to associate with
IAs from 96QN cells. Green fluorescence
indicates the 96QN–GFP proteins and IAs,
blue indicates the DNA stain DAPI, and
red CY-3 fluorophore is used for each indi-
vidual protein tested for localization. Yellow
color indicates colocalization of IAs with the
test protein antibody. (a) Immunostaining
for NFL on 5-d induced 96QN cells. (b)
Immunostaining for actin on 5-d induced
96QN cells. (c) Staining of 96QN cells with
TRITC–phalloidin. (d and e) Magnification
of a region from panel c with separation of
the color channels to highlight colocalization
by comparison of the red actin channel in
panel d with matching signal in of 96QN–
GFP green fluorescence in panel e. Arrows
indicate some of the colocalizing IAs. (f)
Staining of 96QN cells with monoclonal anti-
body 414 against NPCPs. Bright yellow signal
indicates colocalization of NPCP signal with a
subset of IAs. (g and h) Individual color
channels to highlight colocalization of
NPCPs with IAs. White arrows indicate
colocalization of spherical monoclonal anti-
body 414 staining with a subset of IAs, blue
arrows indicate areas of NPCP density on
the nuclear envelope, and orange arrows
indicate colocalization of 96QN–GFP with
these perinuclear densities.Suhr et al. Proteins Sequestered in PolyQ Aggregates 293
Sequestration of p53 and mdm-2
The recruitment of three of the identified proteins (p53,
mdm-2, and NPCP/nucleoporins) may have particular rel-
evance to potential mechanisms of polyQ-mediated toxic-
ity. With regard to p53 and mdm-2, it is unknown at this
time whether their sequestration or interaction with polyQ
proteins is directly mediated through binding with the
polyQ protein, or if they represent proteins that are
brought into IAs through association with other highly re-
cruited proteins. Four highly recruited proteins found or
confirmed in this study to be sequestered within IAs—
ubiquitin, HSP70, TBP, and mdm-2—are also known to
bind p53 (Hughes et al., 1997). Recently, Steffan et al.
(2000) showed that p53 coaggregates with the NH2-termi-
nal region of Htt exon I, a region encompassing both the
polyQ and polyP tracts, in cultured cells and cell extracts.
In addition to cytotoxicity due to polyQ interaction with
intact p53, the indication of lower molecular weight p53
immunoreactive species (p48–p50) observed at high levels
within the purified IA lane suggest another pathological
mechanism. There are several known cleaved forms of
p53. A 50-kD form results from the loss of the NH2-termi-
nal 23 amino acid and is postulated to have intact transac-
tivation and apoptosis-inducing determinants, but to have
lost the domain responsible for protein–protein interac-
tion with mdm-2 (Okorokov et al., 1997). It is tempting to
speculate that the accumulation of the mdm-2–indepen-
dent p50 accounts for increased p53 activity.
A second potential mediator of net increased p53 activ-
ity could arise from the sequestered mdm-2 protein spe-
cies. Sequestered 58–60-kD mdm-2 and a lower molecular
mass 55–56-kD form are observed within IAs. One 58–60-
kD isoform of mdm-2 has been found to be formed by
caspase cleavage in nonapoptotic cells (Olson et al., 1993).
Caspase cleavage to generate the 58–60-kD mdm-2 re-
moves the COOH-terminal domain of mdm-2 involved in
mediating ubiquitination and proteolysis of p53, but not
p53 binding, and predicts that 58–60-kD mdm-2 could
function as a dominant negative factor p53 stabilizer
through competition with full-length mdm-2 (Olson et al.,
1993). The lower molecular weight mdm-2 band observed
only in the IAs at 56/57 kD may represent a novel mdm-2
cleavage product produced by combinations of factors
specific to the environment within the IAs. The accumula-
tion of a putative p53 50-kD form and cleaved mdm-2
within the IAs both provide potential means of altering
p53 activity.
Interaction of Polyglutamine with NPCPs
The possibility of polyQ interaction with proteins of the
nuclear pore and matrix could answer many questions
with regard to localization and toxicity of long-tract polyQ
both in vivo and in cultured cell models. Three lines of ev-
idence link the nucleus to polyQ-mediated toxicity: (a) the
overwhelming majority of reports examining the mecha-
nism of polyQ-mediated toxicity in HD, either through
study of human brain tissue, cultured cells, and animal
models, agree that the onset of symptoms and cytotoxicity
is concurrent with cleavage of the polyQ tract from the
large cytoplasmic Htt molecule and subsequent transloca-
tion of this NH2-terminal fragment into the nucleus; (b)
addition of an NLS accelerates polyQ-mediated toxicity in
cultured cell models; and (c) even though lacking evident
NLSs within the Htt NH2-terminal fragment (or any other
region of Htt), the NH2-terminal polyQ fragment of Htt
(or synthetic polyQ reporters) tends to accumulate within
or surrounding the nucleus, often producing an inpocket
when located adjacent to the nuclear envelope. Indenta-
tion of the nuclear envelope has also been found at high
levels in ultrastructural studies of HD brain (Roos et al.,
1985). Toxic pathways that could result from changes in
the NPC, matrix, or envelope, include alteration or inhibi-
tion of mRNA and protein trafficking between the nucleus
and cytoplasm.
It is our hope that deciphering the contents of IAs in a
cellular model of HD will provide new insight into the
population of proteins that interact with polyQ-bearing
proteins, irrespective of whether sequestration of these
proteins within the IA directly contributes to cell death.
Much of the speculation about potential mechanisms of
polyQ-mediated cell death in this report has focused on
p53 and NPCP because they copurify with IAs at higher
relative levels than most of the other proteins tested; how-
ever, it is equally possible that proteins found at lower lev-
els interact preferentially with soluble or monomeric
polyQ protein and are consequently underrepresented in
IAs. For this reason, even the most weakly recruited fac-
tors should not be dismissed as insignificant to polyQ-
mediated pathology until thoroughly studied.
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